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To define the role of cytokine binding to the IL-2/IL-15Rb chain in protective immunity against systemic infection with
herpes simplex virus type 2 (HSV-2), IL-2/IL-15 receptor(R)b knock-out mice were inoculated intraperitoneally with HSV-2
strain 186. IL-2/IL-15Rb-deficient mice were susceptible to systemic HSV-2 infection compared with their heterozygous
littermates. The emergence of natural killer (NK) cells was impaired in IL-2/IL-15Rb knock-out mice, but CD41 T cell receptor
(TCR) ab1 T cells were normally detected in the peritoneal cavity after infection with HSV-2. However, the generation of
HSV-2-specific CD41 T helper (Th) 1 cells producing interferon-g was impaired in IL-2/IL-15Rb knock-out mice following
HSV-2 infection. The serum IL-15 level in control mice was increased in the early stage after HSV-2 infection but was not
detectable in IL-2/IL-15Rb knock-out mice. In vivo administration of recombinant IL-15 protected normal mice from
HSV-2-induced lethality, accompanied by increases in numbers of NK cells and HSV-2-specific Th1 cells. Taken together,
these results suggest that IL-15, using the IL-2/IL15Rb chain, plays an important role in mounting protective immunity during
the course of systemic HSV-2 infection. © 2000 Academic Press
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cINTRODUCTION
Herpes simplex virus (HSV) is an important human
pathogen that causes a variety of diseases ranging from
mild skin disorders to life-threatening encephalitis (Stan-
berry, 1992; Whitley, 1996). Once HSV invades a healthy
host, the virus establishes latent infection and occasion-
ally causes recurrent disease. Studies in animal models
have demonstrated that both innate immunity mediated
by macrophages (MF) and adaptive immunity by T cell
receptor (TCR) ab1 T cells are required to protect the
host against HSV infection (Whitley, 1996; Schmid and
Rouse, 1992). Although the class I-restricted CD81 cyto-
toxic T lymphocytes (CTL) may play some protective role,
CD41 T helper type 1 (Th1) cells, which uniquely secrete
nterleukin (IL)-2, interferon (IFN)-g, and tumor necrosis
actor-b to induce cellular immunity, are essential for the
ost defense mechanism against HSV infection (Manic-
an et al., 1995a,b; Manickan and Rouse, 1995). Recent
tudies have indicated that natural killer (NK) cells
Fitzgerald et al., 1985; Habu et al., 1984; Rager-Zisman et
l., 1987) and TCR gd T cells (Sciammas et al., 1997) also
play essential roles in protection against murine HSV
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nstitute for Disease Mechanism & Control, Nagoya University Schoola
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57type 1 infection by controlling viral replication and
spread. Mice deficient in IFN-g are susceptible to the
development of cutaneous zosteriform lesions and to
encephalitis (Bouley et al., 1995). Transgenic overexpres-
sion of IFN-g in photoreceptor cells protects mice from
intraocular HSV infection (Geiger et al., 1994). Taken
together, these results suggest that IFN-g is an important
mediator of NK, TCR gd, and TCR ab Th1 cell-mediated
clearance of HSV.
The IL-2 receptor (R) plays a major role in signal trans-
duction for activation and proliferation of NK (Carson et al.,
1994), TCR gd (Kjeldsen-Kragh et al., 1993), and ab T cells
Smith, 1988). IL-2R is composed of at least three subunits,
he a, b, and g chains (Taniguchi and Minami, 1993). Re-
cently, the b chain has been shown to bind IL-15, which is
xpressed in a variety of cells and tissues and has several
iological functions in common with IL-2 (Bamford et al.,
994; Giri et al., 1994; Grabstein et al., 1994; Tagaya et al.,
996). In IL-2/IL-15Rb-deficient mice (IL-2/IL-15Rb2/2 mice),
significant fractions of NK and TCR gd1 cells are disrupted
during development (Suzuki et al., 1997a), whereas mice
lacking IL-2 or IL-2Ra have appreciable numbers of these
cells (Schorle et al., 1991; Simpson et al., 1995). Thus,
cytokines other than IL-2 such as IL-15 that bind to IL-2/IL-
15Rb are important for the development of NK and gd T
ells. Recently, Lodolce et al. showed that IL-15Ra knock-
out mice are deficient in NK cells, memory-type CD81 T
cells, or gd intestinal intraepithelial lymphocytes (Lodolce et
l., 1998). IL-15 has been reported to stimulate NK cells to
0042-6822/00 $35.00
Copyright © 2000 by Academic Press
All rights of reproduction in any form reserved.
ai
c
i
b
s
t
b
s
w
b
n
v
I
t
F
f
P
V
w
1
58 TSUNOBUCHI ET AL.produce IFN-g and exhibit increased cytotoxicity (Carson et
al., 1994, 1995). We as well as other groups have recently
reported that gd T cells (Garcia et al., 1998; Inagaki-Ohara
et al., 1997; Nishimura et al., 1996; Takano et al., 1998) and
memory-type CD81 T cells (Zhang et al., 1998) respond to
IL-15. NK cells (Biron, 1997; Scott and Trinchieri, 1995) and
gd T cells (Emoto et al., 1992; Hiromatsu et al., 1992; Mak
and Ferrick, 1998; Ohga et al., 1990) contribute to early
protection during the course of infection well before antigen
(Ag)-specific ab T cells expand clonally. It is also conceiv-
ble that memory phenotype CD81 T cells play an impor-
tant role in inducing the subsequent adaptive responses to
infection that overcome the first lines of defense. Thus,
IL-15 may contribute to protection against HSV infection via
activation of NK cells, gd T cells, and CD81 T cells express-
ng IL-2Rbhigh.
In this study, we demonstrated that IL-2/IL-15Rb2/2
mice showed an increased susceptibility to systemic
HSV type 2 (HSV-2) infection compared with their het-
erozygous littermates. The appearance of NK cells was
not detected and the generation of HSV-2-specific Th1
cells producing IFN-g was impaired in IL-2/IL-15Rb2/2
mice following HSV-2 infection. Early IL-15 production
was evident in IL-2/IL-15Rb1/2 mice but not in IL-2/IL-
15Rb2/2 mice following HSV-2 infection. In vivo adminis-
tration of rIL-15 augmented the emergence of NK cells
and the generation of Th1 cells producing IFN-g, and
onsequently protected the mice against systemic HSV-2
nfection. These results suggested that IL-15, which
inds to the IL-2/IL-15Rb chain, plays an important role in
the generation of protective immunity against systemic
HSV-2 infection in mice.
RESULTS
Susceptibility of IL-2/IL-15Rb-deficient mice to
systemic HSV-2 infection
We examined the susceptibility of IL-2/IL-15Rb2/2 mice to
ystemic infection with HSV-2. As shown in Fig. 1A, more
han 70% of IL-2/IL-15Rb1/2 mice survived for more than 20
days after an i.p. injection of 186 strain (5 3 103 PFU),
whereas all IL-2/IL-15Rb2/2 mice died within 10 days after
infection with the same dose of HSV-2. The difference
between the survival rates of IL-2/IL-15Rb1/2 mice and
IL-2/IL-15Rb2/2 mice was statistically significant (P , 0.005
y the generalized Wilcoxon test). All IL-2/IL-15Rb1/2 mice
survived for more than 20 days when infected with 5 3 102
PFU of 186 strain, while 60% of the IL-2/IL-15Rb2/2 mice
died. The difference between the survival rates of IL-2/IL-
15Rb1/2 mice and IL-2/IL-15Rb2/2 mice was statistically
ignificant significant (P , 0.01 by the generalized Wilcoxon
test). The total number of mice used for three separate
experiments was 18 for each group.
We compared virus titers in the organs of IL-2/IL-
2/2 1/215Rb and mice on Day 7 after infection with HSV-2
ild-type strain 186 (5 3 103 PFU), at which time the miceegan to die. As shown in Fig. 1B, in IL-2/IL-15Rb2/2 mice
viruses replicated well in the liver and the adrenal gland.
Significant amounts of infectious virus were also detect-
able in the peritoneal cavity of IL-2/IL-15Rb2/2 mice (data
ot shown). On the other hand, no appreciable level of
irus titers was detected in the liver or adrenal gland of
L-2/IL-15Rb1/2 mice using the plaque assay. Thus, these
results indicated that IL-2/IL-15Rb2/2 mice were suscep-
ible to HSV-2 infection.
low cytometric analysis of peritoneal exudate cells
rom IL-2/IL-15Rb-deficient mice after systemic HSV-2
infection
To compare the cellular responses in the peritoneal
FIG. 1. Susceptibility of IL-2/IL-15Rb-deficient mice after infection
with HSV-2. (A) Survival rate of IL-2/IL-15Rb-deficient mice after infec-
tion with HSV-2 strain 186. IL-2/IL-15Rb2/2 mice and their heterozygous
littermates (1/2) were inoculated i.p. with 5 3 103 or 5 3 102 PFU of
HSV-2 strain 186 and monitored for survival. Symbols: IL-2/IL-15Rb2/2
mice infected with 5 3 103 PFU (F) or 5 3 102 PFU (E); IL-2/IL-15Rb1/2
mice infected with 5 3 103 PFU (n ) or 5 3 102 PFU (h). IL-2/IL-15Rb2/2
mice showed higher susceptibility than the control littermates (F vs n ,
, 0.005; E vs h, P , 0.01 by the generalized Wilcoxon test). (B)
irus titers in the liver and adrenal gland following systemic infection
ith HSV-2. Livers and adrenal glands were harvested from IL-2/IL-
5Rb-deficient mice (2/2) and their heterozygous littermates (1/2) 7
days after i.p. inoculation with 5 3 103 PFU of HSV-2 strain 186. Virus
titers were measured using the viral plaque assay. PFU were counted
and averaged from six mice of each group. The data are shown as
means 6 SD.cavity after systemic infection with HSV-2 between IL-2/
IL-15Rb2/2 and IL-2/IL-15Rb1/2 mice, expressions for
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59IL-15 IN HERPES SIMPLEX VIRUS TYPE 2 INFECTION IN MICENK1.1, CD3, TCR ab, TCR gd, CD4, and CD8 on nonad-
erent peritoneal exudate cells (PEC) were examined by
low cytometric (FCM) analysis. Typical results of FCM
nalysis on Day 6 after infection with HSV-2 wild-type
train 186 (5 3 103 PFU) are shown in Fig. 2, and the
relative numbers of five mice/group are summarized in
Table 1. The proportion of NK1.11CD32 cells, which were
representative of NK cells, was increased in the perito-
1/2
FIG. 2. FCM analysis of nonadherent PEC from IL-2/IL-15Rb-deficient
mice on Day 6 after infection with HSV-2 strain 186. IL-2/IL-15Rb2/2
mice and their heterozygous littermates (1/2) were inoculated i.p. with
5 3 103 PFU of HSV-2 strain 186. Six days later, nonadherent PEC were
recovered from five mice of each group and stained with anti-CD3e and
anti-NK1.1 mAbs, with anti-CD3e, anti-TCR gd, and anti-TCR ab mAbs, or
ith anti-CD3e, anti-CD4, and anti-CD8a mAbs. Cells gated on CD31
cells were analyzed for their expression of TCR ab and TCR gd or CD4
nd CD8a. Numbers represent the percentages of total cells found in
ach quadrant. The profile is representative of three independent
xperiments.neal cavity of IL-2/IL-15Rb mice after HSV-2 infection
(Day 0 vs Day 6, p , 0.05). Similarly, the relative number rof CD31CD81 cells was markedly increased in the peri-
oneal cavity of IL-2/IL-15Rb1/2 mice (Day 0 vs Day 6, P ,
0.05). As reported previously (Suzuki et al., 1997a), the
numbers of NK cells and gd T cells were severely re-
duced in IL-2/IL-15Rb2/2 mice, and no increases in these
cells were detected following HSV-2 infection. The pro-
portion of CD81 T cells, most of which expressed CD69
as an activation marker (data not shown), was increased
in IL-2/IL-15Rb2/2 mice before infection, and but it was
not increased in these mice after HSV-2 infection. The
number of CD31CD41 cells in the peritoneal cavity of
IL-2/IL-15Rb2/2 mice was as much as that in IL-2/IL-
5Rb1/2 mice. Thus, the emergence of NK cells and
CD81 T cells was impaired, while the appearance of
CD41 ab T cells was normal, in the peritoneal cavity of
IL-2/IL-15Rb2/2 mice after HSV-2 infection.
Serum IL-2 and IL-15 levels in IL-2/IL-15Rb-deficient
ice after systemic HSV-2 infection
We next monitored serum IL-2 and IL-15 levels follow-
ng HSV-2 infection. As shown in Fig. 3, the IL-15 levels
ere increased in IL-2/IL-15Rb1/2 mice on Days 3 and 6
after HSV-2 infection, whereas such increases were not
evident on Day 3 or 6 after HSV-2 infection. On the other
hand, no appreciable level of IL-2 was detected in the
serum of IL-2/IL-15Rb1/2 mice following HSV-2 infection.
otably, significantly high levels of IL-2 were detected in
he sera of IL-2/IL-15Rb2/2 mice before infection, and the
IL-2 levels remained at an increased level in these mice
after HSV-2 infection. Thus, early IL-15 production was
evident in normal mice after HSV-2 infection, whereas
IL-15 production was impaired in IL-2/IL-15Rb2/2 mice,
which spontaneously produced an appreciable level of
IL-2.
Generation of protective Th1 cells producing IFN-g in
IL-2/IL-15Rb-deficient mice after systemic HSV-2
nfection
We next compared the levels of IFN-g production by
he peritoneal exudate T cells in response to mitomycin
(MMC)-treated spleen cells from HSV-2-infected mice
n IL-2/IL-15Rb2/2 and IL-2/IL-15Rb1/2 mice 6 days after
nfection with HSV-2. As shown in Fig. 4A, the level of
FN-g production by the peritoneal T cells from infected
IL-2/IL-15Rb2/2 mice was significantly lower than that in
the infected IL-2/IL-15Rb1/2 mice in response to HSV-2-
infected spleen cells (P , 0.05) or immobilized anti-TCR
ab mAb (P , 0.05). Cytokine FACS analysis suggested
hat IFN-g was mainly produced by CD41T cells (Fig. 4B).
IL-4 production was undetectable in the culture super-
natants of T cells derived from either IL-2/IL-15Rb2/2 or
IL-2/IL-15Rb1/2 mice (data not shown). T cells from IL-2/
2/2IL-15Rb mice showed normal production of IL-2 in
esponse to TCR ab stimulation, suggesting that the
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60 TSUNOBUCHI ET AL.viability of ab T cells from IL-2/IL-15Rb2/2 mice was
intact during in vitro culture. These results indicated that
eneration of Th1 cells producing IFN-g was impaired in
IL-2/IL-15Rb2/2 mice infected with HSV-2.
Effects of in vivo administration of recombinant IL-15
on protection against HSV-2
Our results suggested that cytokines, such as IL-15,
that recognize the IL-2/IL-15Rb chain may be important
or the generation of protective Th1 cells following sys-
emic HSV-2 infection. We therefore examined the effects
f in vivo administration of recombinant(r) IL-15 on pro-
ection against systemic HSV-2 infection. RIL-15 (0.5 mg/
day) or PBS was injected i.p. 2 h before and on Days 1
and 2 or on Days 1, 2, 3, 4, and 5 after HSV-2 infection. As
shown in Fig. 5, all PBS-treated mice died within 20 days
after infection with a lethal dose of HSV-2 wild-type strain
186 (2 3 104 PFU), whereas 40% of mice given rIL-15 for
3 days and 80% of mice given rIL-15 for 6 days survived
for more than 20 days after infection (P , 0.05, by the
eneralized Wilcoxon test). Thus, in vivo administration
of rIL-15 improved the survival rate of HSV-2-infected
mice.
We next carried out FCM analysis of PEC from mice
receiving rIL-15 for 6 days on Day 6 after infection.
Typical results of FCM analysis are shown in Fig. 6, and
the relative numbers of each subset are summarized in
Table 2. As shown in Fig. 6, in vivo administration of
rIL-15 enhanced the emergence and/or expansion of NK
cells and CD31 T cells during HSV-2 infection. CD81 T
ells appeared to increase to a greater degree than other
ubsets, including CD41 T cells and CD42CD82 T cells,
ollowing rIL-15 administration, although the difference
as not statistically different. Thus, IL-15 administration
T
Expression of NK1.1, CD4, CD8, TCRab, and
and 1/2 Mice before and afte
IL-2Rb
CD31
CD41 CD81
2/2 Day 0 51.6 6 7.2 35.2 6 4.8
Day 6 53.6 6 10.4 37.5 6 12.2
1/2 Day 0 45.4 6 2.8 15.9 6 5.8
Day 6 40.5 6 4.0 33.4 6 5.2*
a IL-2/IL-15Rb-deficient mice (2/2) and their heterozygous littermate
ere harvested and analyzed by FCM. Numbers are means 6 SD perc
s determined by FACS analysis.
* Significantly different from the value for each group of mice on Da
IL-2/IL-15Rb2/2 and 1/2 mice were as follows: on Day 0, 5.3 6 1.4 3 10
05, respectively.articularly enhanced the emergence and/or expansion
f NK cells and T cells following HSV-2 infection.eneration of protective Th1 cells producing IFN-g in
IL-15-treated mice after HSV-2 infection
We next compared the cytokine production and prolif-
eration of the peritoneal exudate T cells in response to
MMC-treated spleen cells from HSV-2-infected mice or
immobilized TCR ab mAb in IL-15-injected and control
BS-injected mice 6 days after i.p. inoculation of HSV-2.
s shown in Fig. 7, the peritoneal T cells from IL-15-
reated mice and from PBS-treated mice proliferated to
lmost the same levels, but the level of IFN-g production
by the peritoneal T cells from IL-15-treated mice was
significantly higher than that from PBS-treated mice in
response to HSV-2-infected spleen cells (P , 0.05). IL-4
roduction was undetectable in the culture supernatants
f peritoneal T cells derived from IL-15- or PBS-treated
ice. These results indicated that administration of
IL-15 accelerated the generation of CD41 Th1 cells
producing IFN-g in mice infected with HSV-2.
DISCUSSION
We showed that mice lacking the IL-2/IL-15Rb chain
were susceptible to systemic infection with HSV-2 com-
pared with their heterozygous littermates. The appear-
ance of NK cells was impaired in IL-2/IL-15Rb2/2 mice
following HSV-2 infection. Although the emergence of
CD41 ab T cells in the peritoneal cavity of infected
IL-2/IL-15Rb2/2 mice was normal, the generation of HSV-
2-specific Th1 cells producing IFN-g was impaired in
L-2/IL-15Rb2/2 mice. Early IL-15 production was evident
in IL-2/IL-15Rb1/2 mice but not in IL-2/IL-15Rb2/2 mice
ollowing HSV-2 infection. In vivo administration of rIL-15
o mice enhanced the NK cell response and generation
f HSV-2-specific Th1 cells producing IFN-g, and it pro-
in the Nonadherent PEC of IL-2/IL-15Rb2/2
tion with HSV-2 Strain 186a
CD31
NK1CD32TCRab1 TCRgd1
91.6 6 4.2 1.1 6 0.6 0.5 6 0.5
96.4 6 0.4 0.7 6 0.5 1.0 6 0.4
89.3 6 1.9 3.9 6 1.4 2.9 6 0.9
91.5 6 1.7 4.0 6 1.7 7.0 6 1.6*
) were inoculated i.p. with 5 3 103 PFU of HSV-2. Nonadherent PEC
s of whole lymphocytes or CD31 cells (CD31) found in each quadrant
, 0.05). Absolute numbers of CD31 cells in the peritoneal cavity of
.1 6 0.4 3 105, respectively; on Day 6, 1.9 6 1.1 3 106 and 8.5 6 1.9 3ABLE 1
TCRgd
r Infec
s (1/2
entage
y 0 (Ptected the mice against HSV-2-induced lethality. These
results suggested that cytokines binding to IL-2/IL-15Rb,
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61IL-15 IN HERPES SIMPLEX VIRUS TYPE 2 INFECTION IN MICEsuch as IL-15, play an important role in mounting protec-
tive immunity in systemic infection of mice with HSV-2.
IL-2 is thought to be a key mediator in protection
against HSV infection. In vivo administration of rIL-2
ugmented the protective immunity to a systemic chal-
enge with HSV type 1 (Rouse et al., 1985). It has been
hown that mice lacking IL-2 show normal CTL re-
ponses against lymphocytic choriomeningitis virus or
accinia virus and that they exhibit only marginal re-
uced Th cell responses against vesicular stomatitis
irus (Kundig et al., 1993). These findings suggested that
ther cytokines that recognize IL-2Rb may compensate
for the lack of IL-2 function in mice lacking this cytokine.
FIG. 3. Production of IL-2 and IL-15 protein in the sera of IL-2/IL-
15Rb-deficient mice following HSV-2 infection. Sera were collected
from IL-2/IL-15Rb2/2 mice and their heterozygous littermates (1/2) i.p.
infected with 5 3 103 PFU of HSV-2 strain 186 at the indicated times,
nd the IL-2 and IL-15 protein levels were determined by mouse IL-2
nd IL-15 ELISA, respectively. The production level of IL-15 protein was
xpressed as net OD absorbance at 450 nm. The IL-15 level at the line
n the figure was shown as the amount of the detection limit. Repre-
entative data from three independent experiments are shown as
eans 6 SD. *Significantly different (P , 0.001); ** significantly dif-
erent (P , 0.0001).IL-15 has recently been shown to bind to the b- and
g-chains of the IL-2 receptor (Bamford et al., 1994; Giri etal., 1994; Grabstein et al., 1994; Tagaya et al., 1996).
lthough IL-15 shares many biological properties with
L-2, IL-15 has several properties distinct from those of
L-2. IL-2 is produced mainly by activated T cells, while
L-15 mRNA is expressed in a wide variety of tissues,
ncluding the placenta, skeletal muscle, kidney, and ac-
ivated monocyte/MF (Grabstein et al., 1994; Tagaya et
l., 1996; Doherty et al., 1996).
The limited expression of IL-2Ra on activated mono-
uclear leukocytes and the unique tissue distribution of
he IL-15Ra component on nonimmune cells (Giri et al.,
1994) suggest that IL-15 may have an activity outside the
immune system, such as anabolic activities on myocytes
and increasing transepithelial resistance on clonic epi-
thelial cells. The present results indicated that IL-15
production occurred in control mice in the early stage
after systemic HSV-2 infection and that rIL-15 adminis-
tration (0.5 mg/day) had a protective effect against sys-
emic HSV-2 infection. IL-15 may be useful for resolution
f systemic HSV infection. Our intraperitoneal model for
SV-2 infection allowed us to analyze the cellular re-
ponses following systemic infection. However, HSV-2
nfection occurs naturally via cutaneous and mucosal
ites of genitalia. IL-15 is known to be produced not only
y activated MF but also epithelial cells (Inagaki-Ohara
t al., 1997). Hence, one can speculate that IL-15 pro-
uced by epithelial cells may play a protective role in
ucosal infection with HSV-2. The possible implications
or therapeutic use of IL-15 in HSV infection will require
urther analyses of the roles of IL-15 in immunopatho-
enesis in mucosal infection with HSV-2.
Mice genetically lacking IL-2Rb or gc have a reduced
number of NK cells (Suzuki et al., 1997a; Cao et al., 1995;
Ohbo et al., 1996). Lodocle et al. recently reported that
IL-15Ra knock-out mice are almost completely deficient
in NK cells, memory-type CD81 T cells and gd intestinal
ntraepithelial lymphocytes (Lodolce et al., 1998). Thus,
IL-15 appears to be a key cytokine in the development of
NK cells and at least significant fractions of CD81 and gd
T cells. Exogenous IL-15 has been reported to regulate
NK cell survival and stimulate NK cells to produce IFN-g
and exhibit increased cytotoxicity (Carson et al., 1994;
Puzanov et al., 1996). IL-15 also causes strong and se-
lective stimulation of memory-phenotype CD81 T cells in
ivo (Zhang et al., 1998). There is evidence of a protective
role for NK cells (Fitzgerald et al., 1985; Habu et al., 1984;
Rager-Zisman et al., 1987; Atedzoe et al., 1997; Flamand
et al., 1996) and gd T cells (Sciammas et al., 1997) in
esponse to systemic HSV infection. In the present study,
e found here that NK and presumably CD81 T cell
esponses were impaired in IL-2/IL-15Rb2/2 mice follow-
ng HSV-2 infection and that in vivo administration of
IL-15 enhanced the responses of these cells to HSV-2
infection. Taken together, these observations suggest
that IL-15 is involved in early protection against HSV-2
infection via activation of NK cells and CD81 T cells well
fr
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sion.
CD41 Th1 cells are principle mediators of host de-
ense against HSV infection (Manickan et al., 1995a,b;
Manickan and Rouse, 1995). We showed here that the
generation of HSV-2-specific Th1 cells was impaired in
IL-2/IL-15Rb2/2 mice following HSV-2 infection. These
esults indicate that signaling through the IL-2/IL-15Rb
chain is important for the generation of Th1 cells from
naive Th cells during systemic HSV-2 infection. There are
several possible reasons why the generation of Th1 cells
was impaired in IL-2/IL-15Rb2/2 mice infected with
SV-2. Although the T cells are aberrantly activated in
aive IL-2/IL-15Rb2/2 mice, there is no in vitro response
of the T cells to specific Ag nor to polyclonal activators in
IL-2/IL-15Rb2/2 mice (Suzuki et al., 1995). Therefore, it
appears that Ag-specific T cells do not expand without
the IL-2/IL-15Rb chain. However, in vivo response of
D41 T cells to super Ag was evident in these mice
(Suzuki et al., 1997b), and we found a reduced, but
significant, level of HSV-2-specific response in IL-2/IL-
15Rb2/2 mice infected with HSV-2. Naive CD41 T cells
nitially stimulated in the presence of IL-12 and IFN-g
tend to develop into CD41 Th1 cells (Abbas et al., 1996;
Hsieh et al., 1993; O’Garra, 1998; Trinchieri, 1995). Early
IFN-g production is mediated by NK cells and gd T cells,
the development of which is severely impaired in IL-2/
IL-15Rb2/2 mice (Hsieh et al., 1993; O’Garra, 1998; Trinch-
ieri, 1995; Flesch et al., 1995; Gazzinelli et al., 1993;
Hilkens et al., 1997). Mice lacking interferon regulatory
factor-1 had an impairment in IL-15 mRNA expression in
bone marrow cells (Ogasawara et al., 1998), suggesting
that IFN-g is essential for IL-15 production. IL-15 produc-
ion was not evident in IL-2/IL-15Rb2/2 mice following
SV-2 infection. Therefore, it is also possible that im-
aired early IFN-g production results in impairments of
IL-15 production and generation of Th1 cells in IL-2/IL-
15Rb2/2 mice following HSV-2 infection. IL-2/IL-15Rb2/2
mice spontaneously developed autoimmune diseases
uninfected mice or mice 3 days after i.p. infection with 1 3 106 PFU
HSV-2 strain 186) or immobilized anti-TCR ab mAb (100 mg/ml). Cyto-
kine levels in the supernatants were determined by ELISA. Data are
means 6 SD of 10 mice of each group. * Significantly different from the
value for T cells from IL-2/IL-15Rb1/2 mice in response to HSV-2-
infected spleen cells or immobilized anti-TCR ab mAb. (P , 0.05)
** Significantly different from the value for T cells stimulated with
noninfected spleen cells (P , 0.005). (B) Intracellular expression of
cytokines in peritoneal T cells of C57BL/6 mice on Day 6 after i.p.
inoculation with HSV-2 strain 186. Mice were inoculated i.p. with 5 3
103 PFU of HSV-2 strain 186. The enriched T cells were cultured with
horbol myristate acetate and ionomycin for 6 h at 37°C, with brefeldin
added for the last 2 h. After 6 h of culture, the cells were harvested
nd surface-stained with anti-CD4 mAb. After surface staining, cells
ere subjected to intracellular cytokine staining using anti-IFN-g or
L-4 mAbs and rat IgG1 as an isotype control. Numbers represent theFIG. 4. (A) IFN-g production by the peritoneal T cells from IL-2/IL-
5Rb-deficient mice on Day 6 after infection with HSV-2 strain 186.
IL-2/IL-15Rb2/2 mice or their heterozygous littermates (1/2) were in-
culated i.p. with 5 3 103 PFU of HSV-2 strain 186. On Day 6 postin-ercentage of total cells found in each quadrant. The profile is repre-
entative of three separate experiments.
e
f
d
i
i
I
s
I
m
m
p
J
c
I
m
P
T
d
C
s
r
c
t
C
63IL-15 IN HERPES SIMPLEX VIRUS TYPE 2 INFECTION IN MICEpresumably due to a defect in regulatory mechanisms by
CD81 T cells (Suzuki et al., 1999). Although the autoim-
mune diseases were not apparently manifested in the
IL-2/IL-15Rb2/2 mice that we used in our experiments,
activated CD81 T cells and serum IL-2 levels were ab-
rrantly increased in these mice before infection. There-
ore, it is also possible that such aberrant cytokine pro-
uction and autoimmune diseases are responsible for
nhibition of the protective mechanisms against HSV-2
nfection in IL-2/IL-15Rb2/2 mice. Further analysis of the
L-2/IL-15Rb signaling pathway involved in the genera-
tion of protective cells is required to clarify these possi-
bilities.
In conclusion, mice lacking the IL-2/IL-15Rb chain
howed susceptibility to systemic infection with HSV-2.
n vivo administration of rIL-15 to normal mice aug-
ented the generation of Th1 cells producing IFN-g and
protection against HSV-2-induced lethality. These results
suggest that IL-15 plays important roles in the generation
of protective immunity against systemic HSV-2 infection.
MATERIALS AND METHODS
Mice
IL-2/IL-15Rb2/2 mice (Suzuki et al., 1995) have been
previously described. A homogenous population was
established by backcrossing heterozygotes to C57BL/6
mice for more than five generations. In each experiment,
age-matched female mice were used. In some experi-
ments, siblings from the same litter were used. Mice
were maintained under specific pathogen-free condi-
FIG. 5. Effects of exogenous IL-15 on survival of mice after infection
with HSV-2 strain 186. Female mice (6 weeks of age) were inoculated
i.p. with 2 3 104 PFU of HSV-2 strain 186. At 2 h before, and daily
thereafter for a further 5 or 2 days, mice (n 5 5) were treated i.p. with
IL-15 (0.5 mg/day) or PBS. Survival rates were monitored for 20 days
postinfection, and survival curves were compared by the generalized
Wilcoxon test. Symbols: E, control; n , IL-15 i.p. 6 times (P , 0.05 vs
ontrol); , IL-15 i.p. 3 times (not significant). The plot is a representa-
ive of three independent experiments.tions and given food and water ad libitum. All mice were
used at 5 to 6 weeks old.
N
rAntibodies and reagents
PE-conjugated anti-TCR gd, anti-NK1.1 and anti-CD8
Ab, FITC-conjugated anti-CD3 mAb, biotin-conjugated
urified anti-TCR ab mAb, Cy-Chrome-conjugated anti-
CD4 mAb, and Cy-Chrome-conjugated streptavidin were
purchased from PharMingen (San Diego, CA). Anti-TCR
ab mAb (H57-597) was a gift from Dr. R. Kubo (National
ewish Center for Immunology and Respiratory Medi-
ine, Denver, CO). Purified anti-murine IL-15 mAb (rat
gG1, G277-3588) and biotin-conjugated anti-murine IL-15
Ab (rat IgG1, G277-3960) were purchased from
harMingen. Human rIL-15 was purchased from Pepro
ech EC LTD. (London, UK). ED50, as determined by the
ose-dependent stimulation of the proliferation of
TLL-2, was found to be ,0.5 ng/ml, corresponding to a
pecific activity .2 3 106 units/mg.
Virus and infections
The 186 strain of wild-type HSV-2 was originally ob-
tained from Fred Rapp, Pennsylvania State University
FIG. 6. FCM analysis of PEC from IL-15-treated mice on Day 6 after
infection with HSV-2 strain 186. Mice were inoculated i.p. with 5 3 103
PFU of HSV-2. Mice were treated with rIL-15 (0.5 mg/day) or PBS 2 h
before and at 1, 2, 3, 4, and 5 days after infection. On Day 6 postinfec-
tion, nonadherent PEC were stained with anti-CD3e and anti-NK1.1, or
with anti-CD3e, anti-TCR ab, and anti-TCR gd, or with anti-CD3e, anti-
D4, and anti-CD8a mAbs. Cells gated on CD31 cells were analyzed
for their expression of TCR ab and TCR gd or of CD4 and CD8a.umbers represent the percentages of total cells found in each quad-
ant. The profile shown is a representative from five mice of each group.
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64 TSUNOBUCHI ET AL.College of Medicine, Hershey, Pennsylvania (Nishiyama
and Rapp, 1981). The viral stock was grown in monolayer
cultures of Vero cells overlain with MEM supplemented
with 5% calf serum, 100 units/ml penicillin, and 100 mg/ml
treptomycin. The stock was stored frozen at 2–5 3 106
PFU/ml and diluted in PBS just before infection. Mice
were infected at 5–6 weeks of age. Mice were injected
i.p. with 5 3 102 to 2 3 104 PFU of strain 186 in 200 ml
BS. In some experiments, mice were injected i.p. with
.5 mg/day of rIL-15, at 2 h before infection and once a
day 2 or 5 days after infection with HSV-2 strain 186.
Assay of virus titers of mouse tissues
Tissues from six mice were individually assayed for
virus infectivity. Samples were stored at 280°C and later
made into 10% (weight/volume) homogenates; after cen-
trifugation at about 1000 g for 20 min, the supernatant
was titrated for infectivity in Vero cells.
Cell preparation
PEC were prepared by centrifuging peritoneal exu-
dates at 110 g for 10 min and suspended at a concen-
tration of 106 cells/ml in RPMI 1640 containing 10% heat-
nactivated FCS, 100 U/ml penicillin, 100 mg/ml strepto-
ycin, and 10 mM Hepes. Cells were plated in the wells
f 100-mm tissue culture dishes (Nunc, Roskilde, Den-
ark) and allowed to adhere for 1 h at 37°C in a humid-
fied atmosphere of 95% air and 5% CO2. Nonadherent
ells were passed over a nylon-wool column and cul-
ured as enriched T cells.
low cytometry
TABLE 2
The Relative Numbers of Peritoneal Lymphocyte in IL-15-Treated
Mice after Infection with HSV-2 Strain 186a
CD31 CD31
NK1CD32CD41 CD81 TCRab1 TCRgd1
PBS 41.9 6 0.0 36.9 6 4.1 88.5 6 4.9 4.6 6 0.5 10.8 6 2.8
L-15 31.9 6 0.6 43.7 6 8.3 89.1 6 5.8 4.1 6 0.3 20.7 6 2.1*
a C57BL/6 mice were inoculated i.p. with 5 3 103 PFU of HSV-2. Mice
were treated with rIL-15 (0.5 mg/day) or PBS 2 h before and on Days 1,
, 3, 4, and 5 postinfection. On Day 6 after infection, nonadherent PEC
ere harvested and analyzed by FCM. Numbers are means 6 SD
ercentages of whole lymphocytes or CD31 cells (CD31) found in each
uadrant as determined by FACS analysis.
* Significantly different compared to the value of PBS-treated mice
P , 0.05). Absolute numbers of CD31 cells and NK1.11CD32 cells in
PBS-treated or IL-15-treated mice were as follows: CD31 cells, 4.08 6
.72 3 105 and 1.03 6 0.37 3 106, respectively; NK1.11CD32 cells,
.04 6 0.40 3 105 and 8.18 6 0.60 3 105, respectively.Nonadherent PEC were stained with FITC-, PE-, and
iotin-conjugated mAbs. To block Fc receptor-mediatedbinding of the mAb, 2.4G2 (anti-Fcg receptor mAb) was
added. All incubation steps were performed at 4°C for 30
min. To detect biotin-conjugated mAb, cells were stained
with Cy-Chrom-conjugated streptavidin after incubation
with the primary mAb. The stained cells were analyzed
using a FACScalibur flow cytometer (Becton-Dickinson,
San Jose, CA). Small lymphocytes were gated by forward
and side scattering.
Cell culture
The enriched T cells from PEC were cultured in 200 ml
of complete culture medium in 96-well flat-bottomed
plates (Falcon, Becton-Dickinson Ltd., Oxford, UK) at a
density of 4–5 3 105 cells/well, with the same number of
MC-treated spleen cells from C57BL/6 mice 3 days
fter i.p. inoculation with 1 3 106 PFU of HSV-2 strain 186
or uninfected C57BL/6 mice, or with anti-TCR ab mAb
100 mg/ml) that had been immobilized on the plates by
rior incubation for 1 h. The cells were cultured for 3
FIG. 7. Effects of rIL-15 on IFN-g production by the peritoneal T cells
from mice on Day 6 after i.p. inoculation with 5 3 103 PFU HSV-2 strain
186. Mice were treated with rIL-15 (0.5 mg/day) or PBS 2 h before and
at 1, 2, 3, 4, and 5 days after infection. On Day 6 postinfection, PEC were
collected and peritoneal T cells were enriched by passing them over a
nylon-wool column. The enriched T cells (4 3 105 cells) were cultured
n the presence of immobilized anti-TCR ab mAb or with or without
MMC-treated spleen cells (4 3 105 cells) from mice uninfected or
nfected with 1 3 106 PFU HSV-2 strain 186 three days previously. (A)
IFN-g production was measured by ELISA in the culture supernatant of
2-day cultures. (B) Proliferation was assessed by [3H]thymidine incor-
poration. * Significantly different from the value for T cells from PBS-
treated mice in response to HSV-2-infected spleen cells (P , 0.05).
Data are representative of three independent experiments, and they
are expressed as means 6 SD of 10 mice.
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65IL-15 IN HERPES SIMPLEX VIRUS TYPE 2 INFECTION IN MICEdays at 37°C under 5% CO2 in air. After culturing for 48 h,
he supernatant was collected to estimate cytokine pro-
uction. In some experiments, cells were pulsed with
3H]thymidine 6 h before harvesting, and then [3H]thymi-
dine incorporation was determined by liquid scintillation
counting.
Cytokine ELISA
The cell-free culture supernatants were collected at
the indicated times. The cytokine activity in the culture
supernatant was assayed by ELISA using an IFN-g, IL-2,
r IL-4 DuoSet ELISA Development System (Genzyme
iagnostics, Cambridge, MA). ELISA for mouse IL-15
as performed in triplicate using purified anti-mouse
L-15 mAb (capture mAb, G277-3588, PharMingen), bi-
tin-conjugated anti-mouse IL-15 mAb (second mAb,
277-3960, PharMingen), and peroxidase-conjugated
treptavidin (detection reagent, Genzyme).
ntracellular cytokine staining
Enriched T cells (2 3 106 cells/ml) were incubated with
25 ng/ml phorbol myristate acetate and 1 mg/ml ionomy-
in for 6 h at 37°C and 5% CO2, with 10 mg/ml brefeldin
A (Sigma) added for the last 2 h in 24-well flat-bottomed
plates (Falcon, Becton-Dickinson Ltd., Oxford, UK) in a
volume of 1 ml RPMI containing 10% FCS. After 6 h of
culture, the cells were harvested, washed once in HBSS
containing 2.5% newborn horse serum and 0.1% NaN3
(staining buffer), and surface-stained in staining buffer
with PE-anti-CD4 mAb (PharMingen). After surface stain-
ing, cells were subjected to intracellular cytokine stain-
ing using the Fast Immune Cytokine System according to
the manufacturer’s instructions (Becton-Dickinson). For
intracellular cytokine staining, we used FITC-anti-IFN-g
or IL-4 mAbs and FITC-conjugated rat IgG1 as an isotype
control (PharMingen). Samples were examined on a
FACScalibur flowcytometer and analyzed using CELL
Quest software (Becton-Dickinson).
Statistical analysis
The statistical significance of differences, except for
differences in lethality data, was determined by Student’s
t test. Statistical significance of differences in lethality
data were analyzed by the generalized Wilcoxon test.
P , 0.05 was taken as significant.
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